Media Summary: This presentation identified recent product-specific guidance (PSG) documents that include detailed language regarding the use ... Air date: Wednesday, February 1, 2023, 12PM Description: The Introduction to the Principles and Practice of Clinical Research ... This presentation addressed the transparency and reporting requirements for ClinicalTrials.gov and clarified the roles of NLM, ...

Fda Nih Regulatory Do S - Detailed Analysis & Overview

This presentation identified recent product-specific guidance (PSG) documents that include detailed language regarding the use ... Air date: Wednesday, February 1, 2023, 12PM Description: The Introduction to the Principles and Practice of Clinical Research ... This presentation addressed the transparency and reporting requirements for ClinicalTrials.gov and clarified the roles of NLM, ...

Photo Gallery

FDA | NIH: Regulatory Do’s and Don'ts: Tips from FDA – CDER Segment
FDA-NIH 2024 | D1S11 - Nonclinical Assessment of Cell and Gene Therapy (CGT) Products to Support....
CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products
CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products
FDA-NIH 2024 | D1S04 - Chemistry, Manufacturing and Controls: Regulatory Considerations and Resource
CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products
CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products
CDER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products
FDA-NIH 2024 | D1S12 - Early Development of Cellular and Gene Therapy in Oncology -Clinical...
CMC Considerations for Biotechnology Product Development: A Regulatory Perspective
FDA-NIH 2024 | D1S05 - Overview of CDER Nonclinical Resources and Guidance for Approaching First...
FDA | NIH: Regulatory Do’s and Don’ts: Tips from FDA – CBER Segment
Sponsored
Sponsored
View Detailed Profile
FDA | NIH: Regulatory Do’s and Don'ts: Tips from FDA – CDER Segment

FDA | NIH: Regulatory Do’s and Don'ts: Tips from FDA – CDER Segment

... Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/

FDA-NIH 2024 | D1S11 - Nonclinical Assessment of Cell and Gene Therapy (CGT) Products to Support....

FDA-NIH 2024 | D1S11 - Nonclinical Assessment of Cell and Gene Therapy (CGT) Products to Support....

... Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/

Sponsored
CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

Learn directly from the

CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

Learn directly from the

FDA-NIH 2024 | D1S04 - Chemistry, Manufacturing and Controls: Regulatory Considerations and Resource

FDA-NIH 2024 | D1S04 - Chemistry, Manufacturing and Controls: Regulatory Considerations and Resource

... Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/

Sponsored
CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

Learn directly from the

CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

Learn directly from the

CDER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

CDER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

Learn directly from the

FDA-NIH 2024 | D1S12 - Early Development of Cellular and Gene Therapy in Oncology -Clinical...

FDA-NIH 2024 | D1S12 - Early Development of Cellular and Gene Therapy in Oncology -Clinical...

... Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/

CMC Considerations for Biotechnology Product Development: A Regulatory Perspective

CMC Considerations for Biotechnology Product Development: A Regulatory Perspective

FDA

FDA-NIH 2024 | D1S05 - Overview of CDER Nonclinical Resources and Guidance for Approaching First...

FDA-NIH 2024 | D1S05 - Overview of CDER Nonclinical Resources and Guidance for Approaching First...

... Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/

FDA | NIH: Regulatory Do’s and Don’ts: Tips from FDA – CBER Segment

FDA | NIH: Regulatory Do’s and Don’ts: Tips from FDA – CBER Segment

... Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/

FDA-NIH 2024 | D1S16 - Medical Device Coverage Initiatives: Connecting with Payors via the Payor...

FDA-NIH 2024 | D1S16 - Medical Device Coverage Initiatives: Connecting with Payors via the Payor...

... Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/

FDA-NIH 2024 | D1S10 - CBER’s CMC Considerations for Early Phase Studies of Cell and Gene Therapy...

FDA-NIH 2024 | D1S10 - CBER’s CMC Considerations for Early Phase Studies of Cell and Gene Therapy...

... Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/

FDA-NIH 2024 | D1S15 - CDRH Medical Device Development Tools (MDDT) Program

FDA-NIH 2024 | D1S15 - CDRH Medical Device Development Tools (MDDT) Program

... Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/

AGDD 2024 | D1S11 - Orally Inhaled Drug Product PSGs: Considerations for Using Modeling and Sim...

AGDD 2024 | D1S11 - Orally Inhaled Drug Product PSGs: Considerations for Using Modeling and Sim...

This presentation identified recent product-specific guidance (PSG) documents that include detailed language regarding the use ...

FDA-NIH 2024 | D1S09 - Regulatory Resources and Avenues for Obtaining Early Guidance from CBER/OTP

FDA-NIH 2024 | D1S09 - Regulatory Resources and Avenues for Obtaining Early Guidance from CBER/OTP

... Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/

FDA Product Regulations Part 1 of 7

FDA Product Regulations Part 1 of 7

Air date: Wednesday, February 1, 2023, 12PM Description: The Introduction to the Principles and Practice of Clinical Research ...

FDA-NIH 2024 | D1S14 - How Can DICE Help You?

FDA-NIH 2024 | D1S14 - How Can DICE Help You?

... Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/

REdI 2024 | D1S07 - ClinicalTrials.gov: Meeting Transparency and Reporting Requirements

REdI 2024 | D1S07 - ClinicalTrials.gov: Meeting Transparency and Reporting Requirements

This presentation addressed the transparency and reporting requirements for ClinicalTrials.gov and clarified the roles of NLM, ...